Biotechnology News

September 25, 2012

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Vince & Associates Clinical Research today announced that it has been awarded a contract with the Food and Drug Administration (FDA), to conduct bioequivalence studies

September 25, 2012

PHILADELPHIA--(BUSINESS WIRE)--Revitas Announces All-Star Lineup for Life Sciences Industry Summit; Top global industry leaders to discuss the changing pharmaceutical landscape

September 25, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources Group is pleased to announce a distinguished lineup of speakers who will be joining its well-regarded Competitive Landscape Seminar Series focusing on Biologics and Biosimilars on October 4,...

September 25, 2012

EVERETT, Wash.--(BUSINESS WIRE)--SNBL USA, has announced the implementation and validation of Johnson Controls’ Metasys® building management system to provide the reliable monitoring and control of temperature and humidity

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scientists have named Genzyme one of the most highly regarded employers in the biopharmaceutical industry for the 10th consecutive year.

September 25, 2012

CAMBRIDGE, Mass. & BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the...

September 25, 2012

EXTON, Pa.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that the average satisfaction rating for Biogen Idec / Elan’s Tysabri has increased...

September 25, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced it has joined AMDeC (Academy for Medical Development and Collaboration) as a Vendor Partner.

September 25, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for non-inflatable supraglottic airway products

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gen9 Expands Scientific Advisory Board to Advance Synthetic Biology

September 25, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Announces New Data on ALS-2200 in People With Hepatitis C, Supporting Advancement into Phase 2 All-Oral Studies in 2012; Ends Development of ALS-2158

September 25, 2012

SAN CARLOS, Calif.--(BUSINESS WIRE)--Atreca, Inc. receives $6 million from Bill & Melinda Gates Foundation to accelerate vaccine and therapeutics discovery and development. Initial partnership focus: malaria, HIV/AIDS, and tuberculosis.

September 25, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--CSA Medical Opens New Facility in Lexington, MA; triples space to advance customer training and product development

September 25, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics announces new trading symbol “OGEN” and trading of shares on both the OTCQB and OTCBB

September 25, 2012

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem‘s Evan L. Rosenfeld, VP of Medical and Scientific Affairs, Medical Device and Diagnostics, and Suzan Olson, Associate Director, Medical Devices, will attend the AdvaMED MedTech Conference

September 25, 2012

STATE COLLEGE, Pa.--(BUSINESS WIRE)--INDIGO Biosciences Inc., the premier provider of nuclear receptor products, has launched its new branding, “KNOW INDIGO,” and tagline, “The Nuclear Receptor Experts.”

September 25, 2012

TORONTO--(BUSINESS WIRE)--Penetration of biomaterial use with implant and periodontal procedures is still low in the Asia Pacific region in comparison to other global markets, leaving significant room for growth.

September 25, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--VitaPath Genetics, Inc., a privately held company leading the exploration of the Vitanome, announced healthcare industry veteran Catherine Burzik has been appointed Chair of its Board of Directors.

September 25, 2012

SEATTLE & SAN DIEGO--(BUSINESS WIRE)--NanoString launches a Single Cell Gene Expression solution that provides researchers with a flexible and highly sensitive approach to discovering differences in cell-to-cell gene expression profiles.

September 25, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (“Elan”) (NYSE: ELN) today announced that its wholly-owned subsidiaries, Elan Finance public limited company (“Elan Finance”) and Elan Finance Corp. (“Elan Corp.” and together with Elan Finance, the...

September 25, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Recent Agreements with Specialty Pharmacy and Other Key Providers Across the Oncology Market Significantly Expand DARA's Coverage

September 25, 2012

TORONTO--(BUSINESS WIRE)--Momentum continues to build as Royal Liverpool and Broadgreen University Hospitals NHS Trust locks its place as one of the top finalists for the prestigious EHI Awards.

September 25, 2012

MORRISVILLE, N.C. & IRVINE, Calif.--(BUSINESS WIRE)--Clinipace Worldwide & Paragon Biomedical jointly announced a definitive merger agreement under which Clinipace has acquired all outstanding shares of the privately-held, Irvine, CA-...

September 24, 2012

COLD SPRING HARBOR, N.Y.--(BUSINESS WIRE)--The EGFR inhibitors Tarceva and Iressa, used against certain lung cancers, reversed Alzheimer’s-like memory loss in two animal models of the disease.

September 24, 2012

SEATTLE--(BUSINESS WIRE)--The Cancer Genome Atlas (TCGA) study published online in Nature supports power of subtyping Breast Cancer by PAM50 into four distinct diseases. NanoString is developing a PAM50-based diagnostic test.

September 24, 2012

--(BUSINESS WIRE)--Octagon Research Solutions, Inc. to Lead Presentation at Informa Life Sciences’ 2nd Annual Conference on eSubmissions

September 24, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE Mkt: NAVB) Posts Lymphoseek® NDA Update to Company Website

September 24, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization announces Therapeutic Workshops on Cancer stem cell therapy, kinase drugs, and ultra rare diseases planned for the upcoming BIO Investor Forum.

September 24, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals's CEO will be participating in the 3rd Annual Cancer Immunotherapy Conference on October 4, 2012, with a webcast presentation at 11:30 a.m.

September 24, 2012

MOSCOW--(BUSINESS WIRE)--In early September the investment committee of Maxwell Biotech Venture Fund (“MBVF”), founded with the participation of the Russian Government’s RVC, approved the binding terms and the amount of an investment in a newly...

September 24, 2012

FORT COLLINS, Colo.--(BUSINESS WIRE)--Study demonstrates that Optiferrin™, a recombinant human transferrin (rhTF) protein produced by Ventria Bioscience, has been shown to be biochemically and structural similar to human transferrin.

September 24, 2012

HOLLISTON, Mass.--(BUSINESS WIRE)--The Clinical Data Interchange Standards Consortium (CDISC) is a global, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission and archival of...

September 24, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife AB (STO:VITR): 1. The meeting adopted a resolution to distribute shares in the subsidiary Xvivo Perfusion AB to company shareholders, whereby one (1) existing share in Vitrolife AB...

September 24, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR): In accordance with the resolution adopted by the Extraordinary General Meeting of shareholders held on September 24, Vitrolife’s transplantation business, which is run in...

September 24, 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/...

September 24, 2012

MADISON, Wis.--(BUSINESS WIRE)--Promega announces the launch of the PowerPlex Fusion System, a 24-locus multiplex that incorporates common and informative loci used throughout the world.

September 24, 2012

ANN ARBOR, Mich. & SANTA FE, N.M.--(BUSINESS WIRE)--NanoBio will present data from three preclinical studies at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium taking place from Sept. 27-30 in Santa Fe, N.M.

September 24, 2012

EXTON, Penn.--(BUSINESS WIRE)--BioTrends Research Group, one of the world’s leading research and advisory firms for specialized biopharmaceutical issues, finds that regardless of disease severity, the majority of rheumatoid arthritis (RA)...

September 24, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that currently, in both China and South Korea, less than one-third of surveyed...

September 24, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, announced today that they will present at the Sickle Cell...

September 24, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--NextBio announced a partnership with Emory University and its Winship Cancer Institute using genomic data to identify unique biomarkers and treatments for patients with multiple myeloma.

September 24, 2012

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical reports that Appleton Medical Services, Inc. purchased an additional MicroThermX® Microwave Ablation System and continues to purchase an increasing number of disposable antennas.

September 24, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (“Elan”) (NYSE: ELN) today announced that its wholly-owned subsidiaries, Elan Finance public limited company (“Elan Finance”) and Elan Finance Corp. (“Elan Corp.” and together with Elan Finance, the...

September 24, 2012

MIAMI--(BUSINESS WIRE)--Governor Jeb Bush, Florida’s 43rd governor, will kick off the BioFlorida Conference with a post-breakfast keynote session on October 8.

September 24, 2012

TAMPA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. Announces the Completion of Enrollment for its ProBiora3 Clinical Trial at the University of Washington

September 24, 2012

LOS ANGELES--(BUSINESS WIRE)--Genesis Biopharma, Inc. (OTC/BB: GNBP), a biotechnology company developing targeted cellular immunotherapies for the treatment of cancer, today announced that cellular immunotherapies for the treatment of cancer was...

September 24, 2012

WASHINGTON--(BUSINESS WIRE)--The Alliance for Biosecurity and MD Becker Partners released a joint industry report titled, "Medical Countermeasures: A Roundtable Discussion."

September 24, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (NASDAQ: PURE), the creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced it has regained compliance with Nasdaq listing requirements, and will continue trading on...